XML 42 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Derivatives (Tables)
 3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The line-items and fair values for these instruments in the Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 was as follows (in thousands):
March 31, 2026December 31, 2025
Interest rate swaps (designated as hedging instruments)
Prepaid expenses and other assets$6,528 $2,190 
Other liabilities3,642 10,323 
Foreign exchange forward contracts (not designated as hedging instruments)
Prepaid expenses and other assets4,911 914 
Other liabilities891 2,062 
Prepaid expenses and other assets and Other liabilities as of March 31, 2026, totaled $134.8 million and $99.5 million, respectively. The increases compared to December 31, 2025 were due primarily to the receipt of a derivative settlement payment made in error by the financial institution counterparty on March 31, 2026. The funds were recorded as restricted cash on March 31, 2026, and returned to the counterparty the following day.
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The effects of interest rate swaps designated as cash flow hedging instruments for the three months ended March 31, 2026 and 2025 were as follows (in thousands):
Gain recognized in OCI, net of tax
Three Months Ended March 31,
Hedging instrument20262025
Interest rate swaps$8,083 $76 
Gain/(loss) reclassified from OCI into income
Three Months Ended March 31,
Income statement line-item20262025
Interest expense, net$(336)$2,663 
Schedule of derivative instruments not designated as hedging instruments
The effects of foreign exchange forward contracts not designated as hedging instruments for the three months ended March 31, 2026 and 2025 were as follows (in thousands):
Three Months Ended March 31,
Income statement line-item20262025
Foreign exchange gain/(loss), net$8,679 $1,494 
Interest expense, net350 (151)